Careprost Eye Drops contain the active ingredient bimatoprost and are primarily used to treat hypotrichosis, a condition characterized by inadequate or insufficient eyelashes. Bimatoprost works by prolonging the growth phase of eyelash follicles, resulting in longer, thicker, and darker eyelashes. Careprost Eye Drops are applied topically to the base of the upper eyelashes once daily using a sterile applicator.
Careprost Eye Drop
$45.00$15.00 per bottel · 3 bottels
Want to order in bulk / B2B price?
Tracked, discreet delivery
Ships in plain packaging with a tracking number. Delivery time for this product: 6 to 15 days. Free shipping on orders above $299.
30 days money back guarantee
Damaged, missing or only part of your order arrived? Choose a new package or a full refund.
Questions before you order?
Call +1 251-332-4105 or email [email protected].
SECURE CHECKOUT
DISCOVER
MasterCard
VISA
Share
| Active Ingredient (Generic Name): | Bimatoprost |
|---|---|
| Manufacturer: | Sun Pharmaceutical Industries Ltd |
| Packaging: | 3.0 ml in 1 packet |
| Strength: | 3.0 ml |
| Delivery Time: | 6 To 15 days |
| SKU: | Careprost Eye Drop |
| Pack sizes | 3 bottels, 6 bottels, 9 bottels, 12 bottels, 15 bottels, 30 bottels |
Be the first to review “Careprost Eye Drop” Cancel reply
Related products
- $25.00 – $65.00Price range: $25.00 through $65.00 Choose Pack This product has multiple variants. The options may be chosen on the product page
GENERAL, OLANZAPINE & MIRTAZAPINE
$240.00 – $1,700.00Price range: $240.00 through $1,700.00 Choose Pack This product has multiple variants. The options may be chosen on the product page- $50.00 – $350.00Price range: $50.00 through $350.00 Choose Pack This product has multiple variants. The options may be chosen on the product page
- Rated 2.00 out of 5$62.00 – $500.00Price range: $62.00 through $500.00 Choose Pack This product has multiple variants. The options may be chosen on the product page



































































Reviews
There are no reviews yet.